Fellowship in Rheumatology at Northwell Health

About us

The Department of Medicine at the Hofstra Northwell School of Medicine offers two positions for a two-year fellowship training program in rheumatology. This program is only for board-eligible internists who have completed three years of training in internal medicine from an accredited training program in the United States or Canada.

The subspecialty program provides supervised training at a level that allows the fellow to acquire the expertise and competency of a specialist in rheumatology, according to the requirements set forth by the Accreditation Council of Graduate Medical Education. The program offers a closely mentored experience in the diagnosis and management of patients with rheumatic diseases in both inpatient and ambulatory settings. Fellows are required to participate in scholarly activities involving teaching and basic and clinical research. A postgraduate PhD or MPH program can be linked with the fellowship program for those fellows interested in pursuing a career in academic medicine.

The rheumatology fellowship program provides comprehensive training in clinical and investigative rheumatology and related basic science to prepare rheumatologists for careers in clinical practice and/or investigative rheumatology. The fellowship program is fully integrated into the activities of the Division of Rheumatology at Hofstra Northwell School of Medicine and the Centers for Autoimmune and Musculoskeletal Diseases and Genetics at the Feinstein Institute for Medical Research.  It includes at least 12 months of clinical training and 9-12 months of a focused research experience. The clinical training occurs in two tertiary care institutions, Long Island Jewish Medical Center and North Shore University Hospital. 

The nearly 1,800 in-patient beds and the two active emergency departments in our hospitals provide the trainee with exposure to large numbers of acutely ill patients. Fellows also participate in continuity care clinic experiences in both institutions as well as in the faculty outpatient practices for a total of two-three half-days per week throughout the length of the training period. 

The program includes training in the performance of joint aspirates and joint and soft tissue injections, the infusion of biologic agents, the performance and interpretation of joint ultrasound, and participation in clinical trials. The presence of accredited subspecialty programs in other disciplines on campus fosters peer interactions that create an outstanding learning environment for rheumatology fellows. Elective rotations in pediatric rheumatology, rehabilitation medicine, sports medicine, orthopedics, skeletal radiology, neurology, metabolic bone and nuclear medicine enable the trainee to develop skills in allied areas.

There is a weekly conference schedule which includes clinical, core and multidisciplinary conferences, case presentations, radiology, journal clubs and a roster of invited speakers. Opportunities for teaching residents and medical students and for continuing medical education at regional and national conferences and workshops are plentiful.

In their second year, fellows choose an area of clinical or basic science research and pursue it actively under the guidance of a faculty member. The Autoimmune and Musculoskeletal Diseases Center and the Boas Center for Genetics at the Feinstein Institute for Medical Research provide opportunities to participate in investigator-initiated clinical trials and in basic and translational research and to take rigorous courses in investigative medicine and in statistics.

A 3 year post-MD PhD training program at the Feinstein Institute is available through the Elmezzi program. A 2-year MPH program is available through Hofstra University.

Application process

Applicants interested in the rheumatology fellowship training program at Northwell Health should apply through the Electronic Residency Application Service (ERAS), which allow applications starting July 1. There is one fellowship position available for a physician who has completed an accredited internal medicine residency-training program.

No applications are reviewed after Aug. 31.

Essential application information includes:

  • Curriculum vitae
  • Four (4) letters of recommendation
  • USMLE or COMLEX results
  • Common application
  • Medical school transcript
  • Program Director’s letter of recommendation

Current fellows

2013-2014 Fellows

Kiley Toder  2012-2014
Ekaterini Zapantis 2013-2015
Cosmin Dascalu 2013-2015
Melinda Collins 2014-2016
Asaf Klein 2014-2016

Fellowship life

Located in a safe and pleasant locale, Northwell Health is at the crossroads between urban and rural environments. We are in proximity to excellent shopping and diverse dining experiences. Whereas most people own cars, trains and buses permit travel around Long Island but are particularly useful for getting to Manhattan.

What We Do for Fun

We work! With Manhattan just 20 miles to the west and a mere 30 minutes by train, the excitement of Broadway is not far away. Head the other way, and you will find yourself in the vineyards and pastoral settings of eastern Long Island. Head south to the endless beaches on the Atlantic Ocean, whereas just a couple miles north of the hospital are calm bays extending off of the Long Island Sound. Whether you like museums, theatre, golf, cycling, or boating, Long Island has it all. And, if you want to travel three major international airports and train stations are nearby.

Our faculty

Program director

Anne Davidson, MBBS
Fellowship Program Director, Division of Rheumatology
Investigator, Feinstein Institute for Medical Research
Professor of Molecular Medicine, Hofstra Northwell School of Medicine

Dr. Davidson is interested in immune tolerance and renal inflammation in SLE. Her research laboratory is at the Feinstein Institute.
ABIM status: Board Certified in Rheumatology.

Additional faculty

Cynthia Beth Aranow, MD
Investigator, Center for Autoimmune and Musculoskeletal Disorders, Feinstein Institute for Medical Research
Associate Professor of Molecular Medicine and Medicine, Hofstra Northwell School of Medicine

Maria-Louise Barilla-Labarca, MD
Assistant Professor, Hofstra Northwell School of Medicine

Betty Diamond, MD
Investigator & Head, Center for Autoimmune and Musculoskeletal Diseases,The Feinstein Institute for Medical Research
Professor of Molecular Medicine and Medicine, Hofstra Northwell School of Medicine

Richard A. Furie, MD
Investigator, The Feinstein Institute for Medical Research
Chief, Division of Rheumatology and Allergy-Clinical Immunology, Northwell Health
Director, Program in Novel Therapeutics
Professor, Hofstra Northwell School of Medicine

Diane Michelle Horowitz, MD
Assistant Professor, Hofstra Northwell School of Medicine

Elena Katzap, DO

Meggan Claire Mackay, MD
Associate Investigator, Autoimmune & Musculoskeletal Disorders, The Feinstein Institute for Medical Research
Associate Professor, Molecular Medicine and Medicine, Hofstra Northwell School of Medicine

Galina S. Marder, MD
Director - Myositis and Vasculitis Center, Long Island Jewish Medical Center
Assistant Professor, Hofstra Northwell School of Medicine

Julie Schwartzman-Morris, MD
Associate Professor, Hofstra Northwell School of Medicine

Recent publications

  1. Furie R, Nicholls K, Cheng TT, et al. Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study. Arthritis Rheumatol 2014;66:379-89.
  2. Zou YR, Diamond B. Fate determination of mature autoreactive B cells. Adv Immunol 2013;118:1-36.
  3. Mosak J, Furie R. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy. Lupus 2013;22:361-71.
  4. Kim SJ, Gregersen PK, Diamond B. Regulation of dendritic cell activation by microRNA let-7c and BLIMP1. J Clin Invest 2013;123:823-33.
  5. Franchin G, Son M, Kim SJ, Ben-Zvi I, Zhang J, Diamond B. Anti-DNA antibodies cross-react with C1q. J Autoimmun 2013;44:34-9.
  6. Diamond B, Honig G, Mader S, Brimberg L, Volpe BT. Brain-reactive antibodies and disease. Annu Rev Immunol 2013;31:345-85.
  7. Bethunaickan R, Berthier CC, Zhang W, Kretzler M, Davidson A. Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks. PLoS One 2013;8:e77489.
  8. Barilla-Labarca ML, Toder K, Furie R. Targeting the complement system in systemic lupus erythematosus and other diseases. Clin Immunol 2013;148:313-21.
  9. Son M, Santiago-Schwarz F, Al-Abed Y, Diamond B. C1q limits dendritic cell differentiation and activation by engaging LAIR-1. Proc Natl Acad Sci U S A 2012;109:E3160-7.
  10. Simpfendorfer KR, Olsson LM, Manjarrez Orduno N, et al. The autoimmunity-associated BLK haplotype exhibits cis-regulatory effects on mRNA and protein expression that are prominently observed in B cells early in development. Hum Mol Genet 2012;21:3918-25.
  11. Mosak J, Furie R. Comparative safety of therapies in systemic lupus erythematosus. Rheum Dis Clin North Am 2012;38:795-807.
  12. Moisini I, Huang W, Bethunaickan R, et al. The Yaa locus and IFN-alpha fine-tune germinal center B cell selection in murine systemic lupus erythematosus. J Immunol 2012;189:4305-12.
  13. Manjarrez-Orduno N, Marasco E, Chung SA, et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet 2012;44:1227-30.
  14. Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 2012;18:871-82.
  15. Horowitz DL, Furie R. Belimumab is approved by the FDA: what more do we need to know to optimize decision making? Curr Rheumatol Rep 2012;14:318-23.
  16. Davidson A. The rationale for BAFF inhibition in systemic lupus erythematosus. Curr Rheumatol Rep 2012;14:295-302.
  17. Bethunaickan R, Sahu R, Liu Z, et al. Anti-tumor necrosis factor alpha treatment of interferon-alpha-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation. Arthritis Rheum 2012;64:3399-408.
  18. Mackay M, Bussa MP, Aranow C, et al. Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration. Mol Med 2011;17:1349-56.
  19. Katzap E, Barilla-LaBarca ML, Marder G. Antisynthetase syndrome. Curr Rheumatol Rep 2011;13:175-81.
  20. Rubinstein T, Pitashny M, Levine B, et al. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford) 2010;49:960-71.
  21. Jacobi AM, Huang W, Wang T, et al. Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum 2010;62:201-10.
  22. Davidson A, Aranow C. Lupus nephritis: lessons from murine models. Nat Rev Rheumatol 2010;6:13-20.
  23. Aranow C, Diamond B, Mackay M. Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 2010;36:187-201, x-xi.
  24. Barilla-Labarca ML, Tsang JC, Goldsmith M, Furie R. Design, implementation, and outcome of a hands-on arthrocentesis workshop. J Clin Rheumatol 2009;15:275-9.

Helpful links

(516) 562-2912
Get in touch with us!

Applicants invited for interview will be notified by email. For additional information on how to apply contact the Beeneka Prashad.

Email the Rheumatology Fellowship Program

Office of Academic Affairs

Offering support services to medical students, residents, fellows and faculty participating in medical education across Northwell Health.